Laurion Capital Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Laurion Capital Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,248	Closed	-$583K	–	1062
2020 Q3	$583K	Buy	+5,248	New	+$564K	0.01%	552
2019 Q4	–	Sell	-5,500	Closed	-$630K	–	1366
2019 Q3	$630K	Buy	+5,500	New	+$547K	﹤0.01%	724
2019 Q2	–	Sell	-3,471	Closed	-$317K	–	1318
2019 Q1	$317K	Buy	+3,471	New	+$284K	﹤0.01%	700
2015 Q4	–	Sell	-6,000	Closed	-$539K	–	1177
2015 Q3	$539K	Sell	6,000 -7,300	-55%	-$771K	0.01%	437
2015 Q2	$1.53M	Buy	+13,300	New	+$1.4M	0.01%	408
2014 Q3	–	Sell	-8,400	Closed	-$374K	–	434
2014 Q2	$374K	Buy	+8,400	New	+$343K	0.01%	244

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Laurion Capital Management's CBPO Position: Q4 2020 in Review

Laurion Capital Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2020, closing a stake of 5,248 shares — an estimated $583K sold.

Laurion Capital Management first reported a position in CBPO in Q2 2014 and held it in 6 quarters. The position peaked at $1.53M in Q2 2015. 89 funds tracked by Wall St. Rank hold CBPO as of Q4 2020.

Laurion Capital Management reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2020 after selling out during the quarter.
Laurion Capital Management sold 5,248 China Biologic Products Holdings, Inc. shares in Q4 2020, an estimated $583K.
Laurion Capital Management first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 6 quarters.
Laurion Capital Management's China Biologic Products Holdings, Inc. position peaked at $1.53M in Q2 2015.
89 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2020.

Based on Laurion Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.